Free. Unsubscribe any time.
BIOMARIN PHARMACEUTICAL INC (BMRN)
BIOMARIN PHARMACEUTICAL INC filed 4 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 4 transactions and 4,698 shares. None carries the SEC's AFF10B5ONE flag; all 4 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2025-05-20, came 14 days after the one before it (2025-05-06) and reports 2 transactions against 2 in the filing before it.
- The sales it reports total 1,786 shares, 1,513 more than the 273 in the filing before it.
- Its 4 filings on file run from 2025-02-25 to 2025-05-20, and state no plan adoption date.
Trades in BIOMARIN PHARMACEUTICAL INC 4
- Burkhart Erin — 2025-02-24 · S · 1,344 shares
- Burkhart Erin — 2025-03-19 · S · 1,295 shares
- Hubbard Cristin — 2025-05-02 · S · 273 shares
- Burkhart Erin — 2025-05-20 · S · 1,786 shares
Adoption dates in BIOMARIN PHARMACEUTICAL INC 0
Results prints in BIOMARIN PHARMACEUTICAL INC 0
Trades before a print in BIOMARIN PHARMACEUTICAL INC 0
Interval to BIOMARIN PHARMACEUTICAL INC’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 4no later print
Sources: SEC EDGAR full-text search and the SEC submissions API.